ADVERTISEMENT
search.svg

Pharmacy News

Federal government makes two announcements with major pharmacy implications in 24 hours

September 9, 2021, was a busy day for the federal government and pharmacy stakeholders alike: Just a few hours apart, we saw significant developments in pharmacists’ COVID-19 pandemic practice authorities and prescription drug pricing. Both items yielded positive news for pharmacists and their patients.

Pharmacists as providers: The last frontier in Alaska

In a recent conversation with a patient’s wife, Justin Ruffridge, PharmD, learned a lot more about the patient’s condition than he expected.

Non-Hispanic Black and Mexican-American adults diagnosed with diabetes at a younger age

New findings published in JAMA Network revealed that non-Hispanic Black and Mexican-American adults were diagnosed with diabetes at a younger age—typically 4 to 7 years earlier—than non-Hispanic whites. 

North Dakota, which once lost its fight to regulate PBM practices, gets a rematch

At the U.S. Eighth Circuit Court of Appeals last week, Pharmaceutical Care Management Association (PCMA) and North Dakota delivered oral arguments in litigation over state laws regulating some PBM practices. The proceedings were the latest step in PCMA v Wehbi’s winding path through the courts. The circuit court once sided with the PBM lobbying group, but the U.S. Supreme Court vacated that ruling after it unanimously decided to uphold an Arkansas PBM-regulation law.

Tocilizumab in short supply due to pandemic

Some individuals with rheumatoid arthritis (RA) are treated with a monthly infusion of the biologic tocilizumab (Actemra—Genentech). However, the drug is now in short supply because of the surge in COVID-19 cases.

RSS
1345678910Last